FLUENT Cannabis Announces Opening of New Dispensary in Brandon, Florida
FLUENT Cannabis (OTCQB: CNTMF) opened a new 2,800 sq ft dispensary in Brandon, Florida, with a grand opening on November 22, 2025. The location at 1401 W Brandon Blvd offers a drive-thru, open showroom with self-ordering kiosks, streamlined point-of-sale, and daily hours from 9:00 a.m. to 8:30 p.m.
The store carries FLUENT’s newest product, 7g Ground Flower, and the grand opening will feature ribbon cutting, promotions, giveaways, brand education and an on-site telehealth office. The company plans new openings in Orlando Sand Lake (December 2025) and Palm Bay (Q1 2026), expanding its network to 39 locations nationwide.
- 2,800 sq ft new retail footprint in Brandon
- Drive-thru and self-ordering kiosks to improve customer throughput
- New in-store product: 7g Ground Flower
- Planned growth to 39 locations with Orlando (Dec 2025) and Palm Bay (Q1 2026)
- None.
Grand Opening Celebration will be Saturday, November 22, 2025
TAMPA, Fla., Nov. 19, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), today announced that its new 2,800 sq ft Brandon, FL dispensary is now open for patients, with a grand opening celebration set for Saturday, November 22, 2025. The new store opening reflects FLUENT’s ongoing strategy to expand in high-demand markets and optimize its retail footprint to better serve patients and drive sustainable growth.
The Brandon location, at 1401 W Brandon Blvd, Brandon, FL 33511 features:
- A drive-thru for convenient service
- An open showroom floor and self-ordering kiosks
- Streamlined point-of-sale process and customer journey
- FLUENT’s newest product release, 7g Ground Flower, available in-store
- Daily hours from 9:00 a.m. to 8:30 p.m.
“Opening in Brandon underscores our disciplined approach to growth,” said Dave Vautrin, Interim CEO of FLUENT. “By focusing investment on high-performing markets and strategic growth opportunities, we’re expanding where demand is strongest, ensuring each location delivers the highest level of service and operational performance and positioning FLUENT to deliver stronger returns while better serving our communities.”
The grand opening celebration on November 22nd will include a ribbon cutting, food truck, doorbuster promotions, giveaways, brand education, special pricing and a telehealth office on-site to assist new patients with medical card consultations. It will be an all-day event throughout the store’s operating hours.
The Company also plans to open new dispensaries in Orlando Sand Lake in December and Palm Bay (Q1 2026), expanding its network to 39 locations nationwide.
For the latest updates on product releases and availability, visit FLUENT’s website or follow the Company on socials:
- Florida – Facebook, Instagram
- New York – Facebook, Instagram
- Pennsylvania – Instagram
- FLUENT Cannabis - LinkedIn, X
About FLUENT Corp.
FLUENT, a national cannabis consumer packaged goods company and retailer, is dedicated to being one of the highest quality cannabis companies for the communities it serves. This is driven by FLUENT's unrelenting commitment to operational excellence in cultivation, production, distribution, and retail experience. FLUENT produces an assortment of cannabis products under a diverse portfolio of brands including MOODS, Knack, Wandr, Bag-O and Hyer Kind. FLUENT operates in Florida, New York, Pennsylvania, and Texas. Headquartered in Tampa, Florida, FLUENT employs 700 employees across 8 cultivation and manufacturing facilities, 37 active retail locations and a wholesale division which trades under ENTOURAGE servicing third party retailers in New York. For more information on the Company’s wholesale division ENTOURAGE, please visit https://entouragewholesale.com/.
FLUENT’s Common Shares trade on the Canadian Securities Exchange under the symbol “FNT.U” and on the OTCQB Venture Market under the symbol “CNTMF”. For more information about the Company, please visit www.getFLUENT.com.
Forward-Looking Information
Certain information in this news release may constitute “forward-looking information” within the meaning of applicable securities laws. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “targets”, “expects” or “does not expect”, “is expected”, “an opportunity exists”, “is positioned”, “estimates”, “intends”, “assumes”, “anticipates” or “does not anticipate” or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might”, “will” or “will be taken”, “occur” or “be achieved” or similar expressions and includes, but is not limited to, statements with respect to FLUENT serving as the exclusive provider of the Connected brands in New York, the anticipated timing for Connected Cannabis and AlienLabs premium branded products to reach retailers and consumers, and the expectation that both FLUENT and ENTOURAGE will continue to feature their growing portfolio of in-house brands in addition to these new offerings. In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent the Company’s expectations, estimates, and projections regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control.
Investors are cautioned that forward-looking information is necessarily based on many opinions, assumptions, and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions, and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the Company’s ability to execute its go-forward strategy; stock market volatility; changes in the business activities, focus and plans of the Company and the timing associated therewith; the timing of any changes to federal laws in the U.S. to allow for the general cultivation, distribution, and possession of cannabis; regulatory and licensing risks; changes in cannabis industry growth and trends; changes in general economic, business and political conditions, including changes in the financial markets; the global regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; risks relating to anti-money laundering laws; compliance with extensive government regulation, including the Company’s interpretation of such regulation; public opinion and perception of the cannabis industry; and the risk factors described in the public filings of the Company filed with Canadian securities regulators and available under the Company’s profile at www.sedarplus.ca.
Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors that could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.
The Company, through several of its subsidiaries, is directly involved in the manufacture, possession, use, sale, and distribution of cannabis in the adult-use and medical cannabis marketplace in the United States. Local state laws where the Company operates permit such activities however, investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Cannabis remains a Schedule I drug under the United States Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute, or possess cannabis in the United States. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable United States federal money laundering legislation.
While the approach to enforcement of such laws by the federal government in the United States has trended toward non-enforcement against individuals and businesses that comply with adult-use and medical cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under United States federal law, nor will it provide a defense to any federal proceeding which may be brought against the Company. The enforcement of federal laws in the United States is a significant risk to the business of the Company and any proceedings brought against the Company thereunder may adversely affect operations and financial performance.
The forward-looking statements contained in this news release are made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law. For further information visit: https://getFLUENT.com/ and https://investors.getFLUENT.com/.
Investor Relations Contact
investors@getFLUENT.com
Media Contact:
press@getFLUENT.com
Officer Contact:
Matt Mundy, Chief Legal Officer
(850) 972-8077
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/cf8b9835-c687-461e-b8cf-9607eaa26688
FAQ
When is FLUENT Cannabis (CNTMF) holding the Brandon dispensary grand opening?
What are the Brandon dispensary hours for FLUENT (CNTMF)?
What features does the new FLUENT (CNTMF) Brandon store include?
What product debut did FLUENT (CNTMF) announce at the Brandon location?
How will FLUENT (CNTMF) expand its retail network after the Brandon opening?
Will FLUENT (CNTMF) offer patient services at the Brandon grand opening?
